ATAC-seq for C42B treated with SR8278 or OE NR1D1; Lucap35CR treated with SR8278
Genome-wide measurements of chromatin accessibility in prostate cancer cells to study the tumorigenic programs. Overall design: ATAC-seq for C42B treated with SR8278 or OE NR1D1; Lucap35CR treated with SR8278